The Gavi Zero-Dose Learning Hub (ZDLH), led by JSI Research & Training Institute, Inc., is pleased to announce the publication of a case study describing the introduction of the typhoid conjugate vaccine (TCV) in Nepal. The case study highlights innovative approaches that successfully identified and reached zero-dose and under-immunized children.
Key findings from the case study include:
This study lays the groundwork for targeted interventions against preventable diseases. Check out the full TCV case study to learn more about the findings.